Insiders · NGM

NGM insider transactions

NGM Biopharmaceuticals Inc. (NGM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

NGM insiders

Everyone who has filed a Form 3, 4, 5 or 144 at NGM Biopharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• TCG Opportunity III GP, LLC10% owner
• Column Group Gp, LP10% owner
• Column Group L PDirector, 10% owner+$58.9M
• David V GoeddelDirector, 10% owner+$28.1M
• Valerie L PierceSVP, GC & Cco, since March 2021
• William Jl RieflinDirector
• Jean-Frederic ViretChief Financial Officer, since November 2023
• David J WoodhouseChief Executive Officer, Director-$300K
• Irene PerlichPrincipal Accounting Officer, since September 2023
• Carole HoDirector
• Shelly D GuyerDirector
• Suzanne Sawochka HooperDirector
• Roger M PerlmutterDirector, since June 2021
• Hsiao D LieuChief Medical Officer-$284K
• Jin-Long ChenOfficer, Director-$6.37M
• Mangini Siobhan NolanOfficer
• Mark LeschlyDirector

Recent Form 3, 4, and 5 filings for NGM

• 946d
  Tcg Opportunity Iii Gp, Llc returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Column Group Gp, Lp returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Column Group L P returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Goeddel David V returned 22,008,593 shares to the company and acquired 1,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Pierce Valerie L closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Rieflin William Jl closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Viret Jean-Frederic closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Woodhouse David J closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Perlich Irene closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  SEC Form 4 filed by Ho Carole

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  SEC Form 4 filed by Guyer Shelly D

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Hooper Suzanne Sawochka closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  SEC Form 4 filed by Perlmutter Roger M

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 946d
  Lieu Hsiao D closing all direct ownership in the company (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1027d
  Lieu Hsiao D covered exercise/tax liability with 5,430 shares, decreasing direct ownership by 9% to 54,254 units (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1027d
  Perlich Irene covered exercise/tax liability with 1,025 shares, decreasing direct ownership by 10% to 8,975 units (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1027d
  Pierce Valerie L covered exercise/tax liability with 5,021 shares, decreasing direct ownership by 8% to 55,374 units (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1027d
  Woodhouse David J covered exercise/tax liability with 13,032 shares, decreasing direct ownership by 9% to 131,822 units (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1072d
  SEC Form 4 filed by Viret Jean-Frederic

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1089d
  Column Group L P bought $15,507 worth of shares (22,631 units at $0.69) (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1089d
  Column Group L P bought $15,507 worth of shares (22,631 units at $0.69) (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1089d
  Column Group L P bought $15,507 worth of shares (22,631 units at $0.69) (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1089d
  Goeddel David V bought $18,332 worth of shares (26,811 units at $0.68), increasing direct ownership by 3% to 134,180 units (SEC Form 4)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1098d
  New insider Viret Jean-Frederic claimed ownership of 38 shares (SEC Form 3)

  3 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1098d
  SEC Form 4 filed by Pierce Valerie L

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1098d
  SEC Form 4 filed by Perlich Irene

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1098d
  SEC Form 4 filed by Woodhouse David J

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1098d
  SEC Form 4 filed by Lieu Hsiao D

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1149d
  SEC Form 3: New insider Perlich Irene claimed ownership of 10,000 shares

  3 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Guyer Shelly D

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Rieflin William Jl

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Hooper Suzanne Sawochka

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Goeddel David V

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Perlmutter Roger M

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1278d
  SEC Form 4 filed by Ho Carole

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1378d
  SEC Form 4: Column Group L P bought $921,110 worth of shares (184,272 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1378d
  SEC Form 4: Column Group L P bought $921,110 worth of shares (184,272 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1378d
  SEC Form 4: Column Group L P bought $921,110 worth of shares (184,272 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1378d
  SEC Form 4: Goeddel David V bought $921,110 worth of shares (184,272 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1385d
  SEC Form 4: Column Group L P bought $49,494 worth of shares (9,900 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1385d
  SEC Form 4: Column Group L P bought $49,494 worth of shares (9,900 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1385d
  SEC Form 4: Column Group L P bought $49,494 worth of shares (9,900 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1385d
  SEC Form 4: Goeddel David V bought $49,494 worth of shares (9,900 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1387d
  SEC Form 4: Column Group L P bought $190,603 worth of shares (38,139 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1387d
  SEC Form 4: Column Group L P bought $190,603 worth of shares (38,139 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1387d
  SEC Form 4: Column Group L P bought $190,603 worth of shares (38,139 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1387d
  SEC Form 4: Goeddel David V bought $190,603 worth of shares (38,139 units at $5.00)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1392d
  SEC Form 4: Chen Jin-Long exercised 85,082 shares at a strike of $1.44 and sold $438,308 worth of shares (85,082 units at $5.15) to satisfy tax liability

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1393d
  SEC Form 4: Column Group L P bought $26,603 worth of shares (5,378 units at $4.95)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1393d
  SEC Form 4: Column Group L P bought $26,603 worth of shares (5,378 units at $4.95)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1393d
  SEC Form 4: Column Group L P bought $26,603 worth of shares (5,378 units at $4.95)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1393d
  SEC Form 4: Goeddel David V bought $26,603 worth of shares (5,378 units at $4.95)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1398d
  SEC Form 4: Column Group L P bought $1,479,359 worth of shares (309,070 units at $4.79)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1398d
  SEC Form 4: Column Group L P bought $1,479,359 worth of shares (309,070 units at $4.79)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1398d
  SEC Form 4: Column Group L P bought $1,479,359 worth of shares (309,070 units at $4.79)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1398d
  SEC Form 4: Goeddel David V bought $1,479,359 worth of shares (309,070 units at $4.79)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1427d
  SEC Form 4: Column Group L P bought $1,493 worth of shares (300 units at $4.98)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1427d
  SEC Form 4: Column Group L P bought $1,493 worth of shares (300 units at $4.98)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1427d
  SEC Form 4: Column Group L P bought $1,493 worth of shares (300 units at $4.98)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)
• 1427d
  SEC Form 4: Goeddel David V bought $1,493 worth of shares (300 units at $4.98)

  4 - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)